Browsing by Titles

Showing results 1 to 4 of 4

  • Nam, Jin Han
  • Cho, Hyun Ji
  • Kang, Hye Jin
  • Lee, Ju Young
  • Jung, Mira
  • Chang, Young Chae
  • Kim, Keetae
  • Hoe, Hyang Sook
  • 2017-12
  • Nam, Jin Han. (2017-12). A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling. doi: 10.1002/jcb.26133
  • John Wiley & Sons Inc.
  • View : 625
  • Download : 0
  • 2022-10
  • Lee, Kyeong-Min. (2022-10). Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression. Biochemical and Biophysical Research Communications, 626, 135–141. doi: 10.1016/j.bbrc.2022.08.021
  • Academic Press
  • View : 299
  • Download : 0

Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression

  • Kim, Hyun Jung
  • Lee, Sukmook
  • Oh, Yong-Seok
  • Chang, Ha Kyun
  • Kim, Young Sang
  • Hong, Sung Hee
  • Kim, Jung Yong
  • Park, Young-Whan
  • Lee, Song-Jae
  • Song, Seong-Won
  • et al
  • 2019-07
  • Kim, Hyun Jung. (2019-07). Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression. doi: 10.3389/fonc.2019.00571
  • Frontiers Media S.A.
  • View : 693
  • Download : 169
  • Preetam, Subham
  • Mondal, Sagar
  • Priya, Swati
  • Bora, Jutishna
  • Ramniwas, Seema
  • Rustagi, Sarvesh
  • Qusty, Naeem F.
  • Alghamdi, Saad
  • Babalghith, Ahmad O.
  • Siddiqi, Abdullah
  • et al
  • 2024-06
  • Preetam, Subham. (2024-06). Targeting tumour markers in ovarian cancer treatment. Clinica Chimica Acta, 559. doi: 10.1016/j.cca.2024.119687
  • Elsevier
  • View : 111
  • Download : 0
1